Financials
Income statement
| Fiscal date | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 |
|---|---|---|---|---|
| Total reported revenue | 8.3B | 10.8B | 12.8B | 15.0B |
| Cost of revenue | 5.0B | 6.8B | 7.8B | 9.2B |
| Gross profit | 3.2B | 4.0B | 5B | 5.8B |
| Operating expense | ||||
| Research & development | 526M | 626M | 567M | 565M |
| Selling general and admin | 972M | 899M | 1.3B | 1.3B |
| Other operating expenses | 249M | -533M | 264M | 295M |
| Operating income | 1.5B | 2.1B | 2.9B | 3.7B |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 829M | 870M | 840M | 836M |
| Other income expense | 246M | 246M | 304M | 238M |
| Pretax income | 895M | 1.5B | 2.4B | 3.1B |
| Tax provision | 27M | 249M | 625M | 751M |
| Net income | 867M | 1.2B | 1.7B | 2.4B |
| Basic EPS | 3.2 | 4.6 | 6.3 | 8.6 |
| Diluted EPS | 3.2 | 4.6 | 6.3 | 8.5 |
| Basic average shares | 271.6M | 272.6M | 274.5M | 276.8M |
| Diluted average shares | 272.3M | 273.6M | 275.6M | 277.9M |
| EBITDA | 2.3B | 2.9B | 3.7B | 4.5B |
| Net income from continuing op. | 867M | 1.2B | 1.7B | 2.4B |
| Minority interests | 2M | 3M | 3M | 2M |
| Preferred stock dividends | — | — | — | — |